Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.51 |
| ▸ | SELL | P14151 | 1/20 | 0.41 |
| ▸ | SELP | P16109 | 1/20 | 0.41 |
| ▸ | SIGLEC7 | Q9Y286 | 7/20 | 0.40 |
| ▸ | MAG | P20916 | 2/20 | 0.39 |
| ▸ | CD22 | P20273 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8459208 | 0.92 | NANP (0.43) | NANPMAGCD22 | |
| SCHEMBL442944 | 0.88 | NANP (0.61) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL6046376 | 0.85 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL13190786 | 0.85 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL29696109 | 0.85 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL28733273 | 0.85 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL8713168 | 0.84 | NANP (0.46) | NANPSELLSELPSIGLEC7 | |
| SCHEMBL9479903 | 0.82 | NANP (0.51) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL2236611 | 0.82 | NANP (0.47) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL8664558 | 0.82 | NANP (0.64) | NANPSELLSELPSIGLEC7MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3677127-A1 | INTESTINAL ENVIRONMENT IMPROVEMENT COMPOSITION AND METHOD FOR MANUFACTURING SAME | Megmilk Snow Brand Co. Ltd. (JP) | 2020-07-08 | — | — | EP | disclosed |
| EP-1775000-A2 | Method of producing universal blood plasma from blood | NCSRT, Inc. (US) | 2007-04-18 | — | — | EP | disclosed |
| EP-1154827-B1 | PURIFICATION OF BIOLOGICAL SUBSTANCES | NCSRT INC (US) | 2006-10-11 | — | — | EP | disclosed |
| US-6946075-B2 | Purification of biological substances | NCSRT, INC. (US) | 2005-09-20 | — | — | US | disclosed |
| US-20030201230-A1 | Purification of biological substances | IGI I ANNEX FUND, L.P. | 2003-10-30 | — | — | US | disclosed |
| EP-1154827-A4 | PURIFICATION OF BIOLOGICAL SUBSTANCES | KOPF HENRY (US) | 2002-08-28 | — | — | EP | disclosed |
| US-6383380-B1 | CHROMATOGRAPHY RESIN | IGI I ANNEX FUND, L.P. | 2002-05-07 | — | — | US | disclosed |
| EP-1154827-A1 | PURIFICATION OF BIOLOGICAL SUBSTANCES | Kopf, Henry (US) | 2001-11-21 | — | — | EP | disclosed |
| US-6139746-A | METHOD EMPLOYING ONE OR MORE CROSS-FLOW FILTER ELEMENTS AND ONE OR MORE TYPES OF CHROMATOGRAPHY RESINS, IN COMBINATION, TO PROVIDE PURIFICATION WITH ADVANTAGEOUS YIELD, PRODUCT PURITY, AND COST- AND TIME-EFFICIENCY | IGI I ANNEX FUND, L.P. | 2000-10-31 | — | — | US | disclosed |
| WO-2000048703-A1 | PURIFICATION OF BIOLOGICAL SUBSTANCES | KOPF HENRY (US) | 2000-08-24 | — | — | WO | disclosed |